Free Trial

Bristol-Myers Squibb (BMY) News Today

$40.50
+0.25 (+0.62%)
(As of 11:28 AM ET)
Stifel Financial Corp Sells 19,979 Shares of Bristol-Myers Squibb (NYSE:BMY)
Stifel Financial Corp lowered its stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 1.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,571,302 shares of the biopharmaceutical company's stock after selling 19,9
Bristol-Myers Squibb (NYSE:BMY) Reaches New 12-Month Low at $41.04
TFO Wealth Partners LLC Has $1.05 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)
TFO Wealth Partners LLC grew its position in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 48,673.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,485 shares of the biopharmaceutical company's
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.9%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.9%
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.7%
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Journey Advisory Group LLC
Journey Advisory Group LLC decreased its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 50.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 29,040 shares of the biopharmaceutical comp
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 0.8%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.8%
Bristol-Myers Squibb (NYSE:BMY) Hits New 1-Year Low at $41.04
Bristol-Myers Squibb (NYSE:BMY) Sets New 1-Year Low at $41.04
Bristol-Myers Squibb (NYSE:BMY) Receives Average Recommendation of "Hold" from Brokerages
Bristol-Myers Squibb (NYSE:BMY - Get Free Report) has been assigned an average rating of "Hold" from the nineteen ratings firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, fifteen have issued a hold recommendation a
United Services Automobile Association Acquires 542,253 Shares of Bristol-Myers Squibb (NYSE:BMY)
United Services Automobile Association increased its holdings in Bristol-Myers Squibb (NYSE:BMY - Free Report) by 965.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 598,432 shares of the
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.7%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 0.7%
3 Blue-Chip Stocks to Buy at 52-Week Lows in May
234,174 Shares in Bristol-Myers Squibb (NYSE:BMY) Acquired by Cantor Fitzgerald Investment Advisors L.P.
Cantor Fitzgerald Investment Advisors L.P. purchased a new position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 234,174 shares of the biopharmace
Bristol-Myers Squibb (NYSE:BMY) Shares Down 0.7%
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Nomura Asset Management Co. Ltd.
Nomura Asset Management Co. Ltd. lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 971,591 shares of the biopharmaceutica
Bristol-Myers Squibb (NYSE:BMY) Stake Raised by Primecap Management Co. CA
Primecap Management Co. CA grew its holdings in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 14.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,534,378 shares of the biopharmace
Bristol-Myers Squibb (NYSE:BMY) Upgraded to "Strong-Buy" at StockNews.com
StockNews.com upgraded shares of Bristol-Myers Squibb from a "buy" rating to a "strong-buy" rating in a report on Thursday.
Oxford Asset Management LLP Buys New Position in Bristol-Myers Squibb (NYSE:BMY)
Oxford Asset Management LLP acquired a new stake in Bristol-Myers Squibb (NYSE:BMY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 20,713 shares of the biopharmaceutical company's stock, va
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
Bristol-Myers Squibb (NYSE:BMY) Trading Down 1.1%
Bristol-Myers Squibb (NYSE:BMY) Holdings Decreased by Oxler Private Wealth LLC
Oxler Private Wealth LLC reduced its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 72.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,925 shares of the biopharmaceutical company's stock after
Pfizer to Cut Costs in Multi-Year Effort
Bristol-Myers Squibb (NYSE:BMY) Trading 1.2% Higher
Bristol-Myers Squibb (NYSE:BMY) Trading 1.2% Higher
Oxler Private Wealth LLC Has $1.66 Million Position in Bristol-Myers Squibb (NYSE:BMY)
Oxler Private Wealth LLC lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY - Free Report) by 285.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,552 shares of the biopharmaceutical company's stock afte
Bristol-Myers Squibb (NYSE:BMY) Stock Price Down 1.4%
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.4%
Bristol-Myers Squibb (NYSE:BMY) Hits New 12-Month Low at $42.95
Bristol-Myers Squibb (NYSE:BMY) Reaches New 1-Year Low at $42.95
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.

Tech GIANT’s Plans to Revolutionize Crypto… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

Biotech Boom: Stocks Skyrocketing & What's Next

BMY Media Mentions By Week

BMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMY
News Sentiment

0.64

0.80

Average
Medical
News Sentiment

BMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMY Articles
This Week

34

23

BMY Articles
Average Week

Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:BMY) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners